Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals disclosed inducement grants to eight new employees under Nasdaq Listing Rule 5635(c)(4). The Compensation Committee approved 10,100 non-qualified stock options and 13,350 restricted stock units, totaling 23,450 shares.
Key figures
- Rsus granted
- 13350
- Options granted
- 10100
- New employees hired
- 8
- Option exercise price
- 94
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.